Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Ed Rayner to its Board of Directors as a Non-Executive Director.
FTC expands pharma scrutiny to early-stage deals, forcing Sanofi to drop Pompe disease partnership with Maze
The Federal Trade Commission said it would seek to block Sanofi’s proposed licensing deal for Maze Therapeutics’ clinical-stage Pompe disease treatment, leading the French pharma
December 12, 2023